AFT Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
AFT Pharmaceuticals has a total shareholder equity of NZ$83.5M and total debt of NZ$30.0M, which brings its debt-to-equity ratio to 36%. Its total assets and total liabilities are NZ$147.9M and NZ$64.4M respectively. AFT Pharmaceuticals's EBIT is NZ$19.2M making its interest coverage ratio 6. It has cash and short-term investments of NZ$10.7M.
Key information
36.0%
Debt to equity ratio
NZ$30.04m
Debt
| Interest coverage ratio | 6x |
| Cash | NZ$10.69m |
| Equity | NZ$83.53m |
| Total liabilities | NZ$64.36m |
| Total assets | NZ$147.89m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AFP's short term assets (NZ$86.8M) exceed its short term liabilities (NZ$31.9M).
Long Term Liabilities: AFP's short term assets (NZ$86.8M) exceed its long term liabilities (NZ$32.4M).
Debt to Equity History and Analysis
Debt Level: AFP's net debt to equity ratio (23.2%) is considered satisfactory.
Reducing Debt: AFP's debt to equity ratio has reduced from 314.1% to 36% over the past 5 years.
Debt Coverage: AFP's debt is well covered by operating cash flow (85.7%).
Interest Coverage: AFP's interest payments on its debt are well covered by EBIT (6x coverage).